Kilitch Drugs
339.70
+12.80(+3.92%)
Market Cap₹593.82 Cr
PE Ratio21.66
IndustryHealthcare
Company Performance:
1D+3.92%
1M-5.74%
6M-23.66%
1Y+11.06%
5Y+278.07%
View Company Insightsright
More news about Kilitch Drugs
20May 25
Kilitch Drugs Reports Impressive Q4 Results with Soaring Profits and Revenue
Kilitch Drugs announced impressive Q4 financial results, with net profit more than doubling to ₹104.40 crore from ₹46.80 crore year-over-year. The company's revenue surged to ₹563.00 crore, up from ₹391.00 crore in the same quarter last year. Sequentially, net profit also showed significant improvement, increasing from ₹56.50 crore in the previous quarter.
 no imag found
Kilitch Drugs
339.70
+12.80
(+3.92%)
1 Year Returns:+11.06%
Industry Peers
Sun Pharmaceutical
1,708.30
(+4.94%)
Divis Laboratories
6,242.00
(+4.86%)
Torrent Pharmaceuticals
4,026.10
(+0.98%)
Cipla
1,325.00
(+1.02%)
Dr Reddys Laboratories
1,234.70
(+4.41%)
Lupin
2,187.20
(+2.71%)
Zydus Life Science
896.75
(+1.94%)
Mankind Pharma
2,168.50
(+5.07%)
Aurobindo Pharma
1,238.20
(+5.74%)
Alkem Laboratories
5,734.50
(+3.86%)